There is little evidence for the direct role of CXCR3 in the development of DN, and a previous study has reported a significantly elevated urinary level of CXCL9 in patients with primary renal disease and increased urinary level albumin excretion rate (37). This evidence concerns the gene CXCL9 and liver dysplastic nodule.